search
Back to results

Weight Loss in Chronic Disease Patient Population

Primary Purpose

Overweight, Obesity, Diabetes

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Tele-health Home Monitoring
TrestleTree Telephone Coaching
Tele-health Home Monitoring Plus Trestle Telephone Coaching
Sponsored by
Ronald Horswell
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Overweight focused on measuring overweight, obese, type II diabetes, hypertension

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age ≥ 18 yrs old
  • BMI ≥ 25 kg/m2 and waist circumference > 40 inches (men)/ 35 inches (women)
  • Weight ≤ 500lbs
  • At least one of the following:
  • Fasting blood sugar > 100 mg/dL at any point and/or taking medications for diabetes And/Or
  • Resting blood pressure > 130/90 mm Hg at any point and/or taking medications for hypertension
  • Not involved in regular physical activity or weight loss management programs
  • Capable of being physically active
  • Physically able to use in-home equipment (or presence of a household member who can assist the subject in equipment use)
  • Currently-working conventional telephone line at primary residence
  • Grounded electrical power supply at primary residence
  • Have been in LSU HCSD system for 6 months and anticipate remaining in the LSU HCSD patient population for the next 6 months

Exclusion Criteria:

  • A history of drug abuse in the last year, or excess alcohol consumption (40g/day)6
  • Currently dieting or engaging in any activity with the goal of losing weight
  • Significant weight loss or weight gain in the past year (> 50 lbs) or current use of weight loss medications
  • History of gastrointestinal bypass or other bariatric surgery in the last 3 years
  • Diagnosis of congestive heart failure
  • Under treatment for end-stage renal disease or end-stage liver disease
  • History of major organ transplant
  • History of cancers requiring treatment in the past 5 years with anything but excellent prognosis
  • Current diagnosis of schizophrenia, bipolar disorder, or other psychotic disorders
  • Pregnant or plan on becoming pregnant in the next 12 months.
  • Lack support from health care provider or family members.
  • Current member of household participating in study
  • Factors that may limit adherence to intervention or affect conduct of the trial.
  • Unable or unwilling to communicate with staff, to provide written informed consent, or accept the randomized assignment.
  • Any other condition, which, in the opinion of the investigators would impede competence or compliance or possibly hinder completion of the study.

Sites / Locations

  • Earl K. Long Medical Center
  • Leonard J. Chabert Medical Center
  • WO Moss Regional Medical Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

No Intervention

Active Comparator

Active Comparator

Arm Label

Tele-health Home Monitoring

Self-Directed Group

TrestleTree Telephone Coaching

Home monitoring + telephone coach

Arm Description

Participants will use the tele-health monitoring equipment to measure daily weight.

Participants will receive information on physical activity recommendations and guidelines on nutrition aimed at promoting weight loss.

Participants will speak to Trestletree health coaches for 15 to 60 minutes each session. During these sessions, the coaches will identify the participant's stage of change and intervene accordingly. The telephone calls will be centered on weight loss.

System to track stage of change in weight loss.

Outcomes

Primary Outcome Measures

Change in Body Weight
Body weight at five-month follow-up minus baseline body weight. Body weight is measured in pounds
Change in Waist Circumference
Waist circumference at five-month follow-up minus waist circumference at baseline. Waist circumference is measured in centimeters.

Secondary Outcome Measures

Change in Systolic Blood Pressure
Change is systolic blood pressure (mmHg) from baseline to five-month follow-up.
Change in Diastolic Blood Pressure
Change in diastolic blood pressure (mmHg) from baseline to follow-up.
Change in HbA1c
Change in HbA1c value from baseline to five-month follow-up among those completing the study through five months.
Change in Triglycerides
Change from baseline to five month follow-up in triglyceride level.
Change in Total Cholesterol
Change in total cholesterol level from baseline to five-month follow-up.
Change in Fasting Plasma Glucose
Change from baseline to five-month follow-up in fasting plasma glucose level.

Full Information

First Posted
June 29, 2010
Last Updated
December 3, 2020
Sponsor
Ronald Horswell
Collaborators
Louisiana State University Health Care Services Division
search

1. Study Identification

Unique Protocol Identification Number
NCT01155050
Brief Title
Weight Loss in Chronic Disease Patient Population
Official Title
Louisiana State University Health Care Services Division (LSUHCSD) Tele-Health Projects: Weight Loss in Chronic Disease Patient Population
Study Type
Interventional

2. Study Status

Record Verification Date
December 2020
Overall Recruitment Status
Completed
Study Start Date
January 2010 (undefined)
Primary Completion Date
December 2010 (Actual)
Study Completion Date
December 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Ronald Horswell
Collaborators
Louisiana State University Health Care Services Division

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study will assess the effect of in-home tele-health monitoring on health outcomes for LSUHCSD chronic disease, overweight or obese patients diagnosed with type II diabetes or hypertension.
Detailed Description
This study will assess the effect of in-home tele-health monitoring on health outcomes for LSUHCSD chronic disease, overweight or obese patients diagnosed with type II diabetes or hypertension. Primary emphasis will be on assessing the effect of tele-health home monitoring combined with motivational telephone coaching on weight loss and waist circumference as compared to self-directed, home monitoring alone, and telephone coaching alone. Secondary outcomes such as blood pressure, Hemoglobin A1c (HbA1c), fasting blood sugar, and cholesterol will be examined as well.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Overweight, Obesity, Diabetes, Hypertension
Keywords
overweight, obese, type II diabetes, hypertension

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The study randomized consenting subjects to four arms for evaluation of different weight loss strategies.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
202 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Tele-health Home Monitoring
Arm Type
Active Comparator
Arm Description
Participants will use the tele-health monitoring equipment to measure daily weight.
Arm Title
Self-Directed Group
Arm Type
No Intervention
Arm Description
Participants will receive information on physical activity recommendations and guidelines on nutrition aimed at promoting weight loss.
Arm Title
TrestleTree Telephone Coaching
Arm Type
Active Comparator
Arm Description
Participants will speak to Trestletree health coaches for 15 to 60 minutes each session. During these sessions, the coaches will identify the participant's stage of change and intervene accordingly. The telephone calls will be centered on weight loss.
Arm Title
Home monitoring + telephone coach
Arm Type
Active Comparator
Arm Description
System to track stage of change in weight loss.
Intervention Type
Device
Intervention Name(s)
Tele-health Home Monitoring
Other Intervention Name(s)
Home Monitoring
Intervention Description
Daily tele-health monitoring data will be collected from randomized participants.
Intervention Type
Behavioral
Intervention Name(s)
TrestleTree Telephone Coaching
Other Intervention Name(s)
Telephone Coaching
Intervention Description
Weekly or bi-weekly phone calls from TrestleTree health coaches with a focus on weight loss.
Intervention Type
Device
Intervention Name(s)
Tele-health Home Monitoring Plus Trestle Telephone Coaching
Other Intervention Name(s)
Home Monitoring and telephone coaching
Intervention Description
Daily collection of data through the tele-health home monitor and weekly or bi-weekly phone calls with a Trestletree Health Coach.
Primary Outcome Measure Information:
Title
Change in Body Weight
Description
Body weight at five-month follow-up minus baseline body weight. Body weight is measured in pounds
Time Frame
five-month follow-up compared to baseline
Title
Change in Waist Circumference
Description
Waist circumference at five-month follow-up minus waist circumference at baseline. Waist circumference is measured in centimeters.
Time Frame
five-month follow-up compared to baseline
Secondary Outcome Measure Information:
Title
Change in Systolic Blood Pressure
Description
Change is systolic blood pressure (mmHg) from baseline to five-month follow-up.
Time Frame
Systolic blood pressure (mmHg) at five months minus systolic blood pressure at baseline.
Title
Change in Diastolic Blood Pressure
Description
Change in diastolic blood pressure (mmHg) from baseline to follow-up.
Time Frame
Diastolic blood pressure (mmHg) at five months minus diastolic blood pressure at baseline.
Title
Change in HbA1c
Description
Change in HbA1c value from baseline to five-month follow-up among those completing the study through five months.
Time Frame
five months
Title
Change in Triglycerides
Description
Change from baseline to five month follow-up in triglyceride level.
Time Frame
five months
Title
Change in Total Cholesterol
Description
Change in total cholesterol level from baseline to five-month follow-up.
Time Frame
five months
Title
Change in Fasting Plasma Glucose
Description
Change from baseline to five-month follow-up in fasting plasma glucose level.
Time Frame
five months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 yrs old BMI ≥ 25 kg/m2 and waist circumference > 40 inches (men)/ 35 inches (women) Weight ≤ 500lbs At least one of the following: Fasting blood sugar > 100 mg/dL at any point and/or taking medications for diabetes And/Or Resting blood pressure > 130/90 mm Hg at any point and/or taking medications for hypertension Not involved in regular physical activity or weight loss management programs Capable of being physically active Physically able to use in-home equipment (or presence of a household member who can assist the subject in equipment use) Currently-working conventional telephone line at primary residence Grounded electrical power supply at primary residence Have been in LSU HCSD system for 6 months and anticipate remaining in the LSU HCSD patient population for the next 6 months Exclusion Criteria: A history of drug abuse in the last year, or excess alcohol consumption (40g/day)6 Currently dieting or engaging in any activity with the goal of losing weight Significant weight loss or weight gain in the past year (> 50 lbs) or current use of weight loss medications History of gastrointestinal bypass or other bariatric surgery in the last 3 years Diagnosis of congestive heart failure Under treatment for end-stage renal disease or end-stage liver disease History of major organ transplant History of cancers requiring treatment in the past 5 years with anything but excellent prognosis Current diagnosis of schizophrenia, bipolar disorder, or other psychotic disorders Pregnant or plan on becoming pregnant in the next 12 months. Lack support from health care provider or family members. Current member of household participating in study Factors that may limit adherence to intervention or affect conduct of the trial. Unable or unwilling to communicate with staff, to provide written informed consent, or accept the randomized assignment. Any other condition, which, in the opinion of the investigators would impede competence or compliance or possibly hinder completion of the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Timothy S. Church, MD, MPH, PhD
Organizational Affiliation
Pennington Biomedical Research Center
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Donna H. Ryan, MD
Organizational Affiliation
Pennington Biomedical Research Center
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Valerie H. Myers, PhD
Organizational Affiliation
Pennington Biomedical Research Center
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Ronald W. Horswell, PhD
Organizational Affiliation
Pennington Biomedical Research Center
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Monisha Chadha, MD
Organizational Affiliation
Louisiana State University Health Care Services Division
Official's Role
Principal Investigator
Facility Information:
Facility Name
Earl K. Long Medical Center
City
Baton Rouge
State/Province
Louisiana
ZIP/Postal Code
70806
Country
United States
Facility Name
Leonard J. Chabert Medical Center
City
Houma
State/Province
Louisiana
ZIP/Postal Code
70363
Country
United States
Facility Name
WO Moss Regional Medical Center
City
Lake Charles
State/Province
Louisiana
ZIP/Postal Code
70607
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Weight Loss in Chronic Disease Patient Population

We'll reach out to this number within 24 hrs